Jeffrey W. Albers

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey W. Albers:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp Director Stock Option (Right to Buy) 0 $9.33M $95.67 17 Jul 2025 Direct
Spyre Therapeutics, Inc. Director Common Stock 27.4K $1.01M $36.76 06 Nov 2024 By Sessions LLC
Blueprint Medicines Corp Director Common Stock 0 $0 $101.84 17 Jul 2025 Direct
Kymera Therapeutics, Inc. Director Common Stock 0 $0 $59.19 13 Oct 2025 Direct
Spyre Therapeutics, Inc. Director Stock Option (Right to Buy) 25K 29 May 2025 Direct
Magenta Therapeutics, Inc. Director Stock Option (Right to Buy) 20K 28 Jun 2022 Direct
Kymera Therapeutics, Inc. Director Stock Option (Right to Buy) 0 13 Oct 2025 Direct

Insider Reports Filed by Jeffrey W. Albers

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KYMR Kymera Therapeutics, Inc. 13 Oct 2025 3 -$244K 4 Director 14 Oct 2025, 07:55
BPMC Blueprint Medicines Corp 17 Jul 2025 10 $0 4 Director 21 Jul 2025, 19:44
KYMR Kymera Therapeutics, Inc. 25 Jun 2025 1 $0 4 Director 26 Jun 2025, 21:00
BPMC Blueprint Medicines Corp 18 Jun 2025 1 $500K 4 Director 24 Jun 2025, 16:28
KYMR Kymera Therapeutics, Inc. 03 Jun 2025 3 -$245K 4 Director 03 Jun 2025, 18:30
SYRE Spyre Therapeutics, Inc. 29 May 2025 1 $0 4 Director 02 Jun 2025, 16:34
BPMC Blueprint Medicines Corp 27 May 2025 4 -$325K 4 Director 29 May 2025, 16:20
BPMC Blueprint Medicines Corp 12 Mar 2025 4 -$388K 4 Director 14 Mar 2025, 16:36
BPMC Blueprint Medicines Corp 05 Mar 2025 1 -$512K 4 Director 17 Mar 2025, 16:26
BPMC Blueprint Medicines Corp 21 Jan 2025 5 -$1.3M 4 Director 23 Jan 2025, 19:53
BPMC Blueprint Medicines Corp 13 Jan 2025 3 -$331K 4 Director 15 Jan 2025, 18:04
BPMC Blueprint Medicines Corp 19 Dec 2024 6 -$1.35M 4 Director 20 Dec 2024, 16:15
BPMC Blueprint Medicines Corp 07 Nov 2024 3 -$330K 4 Director 12 Nov 2024, 16:15
SYRE Spyre Therapeutics, Inc. 06 Nov 2024 1 -$246K 4 Director 08 Nov 2024, 16:53
SYRE Spyre Therapeutics, Inc. 25 Oct 2024 1 -$10.9K 4 Director 28 Oct 2024, 16:41
BPMC Blueprint Medicines Corp 09 Sep 2024 4 -$1.33M 4 Director 11 Sep 2024, 16:06
KYMR Kymera Therapeutics, Inc. 26 Aug 2024 3 -$194K 4 Director 26 Aug 2024, 18:31
KYMR Kymera Therapeutics, Inc. 18 Jun 2024 1 $0 4 Director 20 Jun 2024, 17:00
BPMC Blueprint Medicines Corp 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 17:41
SYRE Spyre Therapeutics, Inc. 14 May 2024 1 $0 4 Director 16 May 2024, 16:10
BPMC Blueprint Medicines Corp 20 Mar 2024 9 -$2.01M 4 Director 22 Mar 2024, 17:50
BPMC Blueprint Medicines Corp 07 Mar 2024 1 -$1M 4 Director 26 Mar 2024, 21:11
KYMR Kymera Therapeutics, Inc. 20 Feb 2024 6 -$144K 4 Director 21 Feb 2024, 18:46
BPMC Blueprint Medicines Corp 25 Jan 2024 8 -$1.87M 4 Director 29 Jan 2024, 18:13
KYMR Kymera Therapeutics, Inc. 23 Jan 2024 3 -$197K 4 Director 23 Jan 2024, 19:37
BPMC Blueprint Medicines Corp 11 Dec 2023 3 -$215K 4 Director 13 Dec 2023, 15:56
BPMC Blueprint Medicines Corp 30 Nov 2023 3 -$173K 4 Director 04 Dec 2023, 16:02
BPMC Blueprint Medicines Corp 24 Nov 2023 4 -$985K 4 Director 28 Nov 2023, 16:05
SYRE Spyre Therapeutics, Inc. 22 Nov 2023 3 $0 4/A Director 08 Dec 2023, 16:07
SYRE Spyre Therapeutics, Inc. 22 Nov 2023 0 $0 3/A Director 08 Dec 2023, 16:03
BPMC Blueprint Medicines Corp 01 Nov 2023 10 -$241K 4 Director 03 Nov 2023, 17:07
BPMC Blueprint Medicines Corp 27 Sep 2023 8 -$1.2M 4 Director 29 Sep 2023, 15:36
BPMC Blueprint Medicines Corp 24 Aug 2023 6 -$1.2M 4 Director 28 Aug 2023, 19:23
BPMC Blueprint Medicines Corp 21 Jun 2023 2 $0 4 Director 23 Jun 2023, 19:07
KYMR Kymera Therapeutics, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 16:15
BPMC Blueprint Medicines Corp 06 Mar 2023 2 -$447K 4 Director 08 Mar 2023, 20:28
BPMC Blueprint Medicines Corp 05 Dec 2022 5 -$833K 4 Director 07 Dec 2022, 19:52
BPMC Blueprint Medicines Corp 19 Aug 2022 7 -$554K 4 Director 23 Aug 2022, 17:53
BPMC Blueprint Medicines Corp 16 Aug 2022 7 -$1.2M 4 Director 18 Aug 2022, 19:55
BPMC Blueprint Medicines Corp 08 Aug 2022 5 -$632K 4 Director 10 Aug 2022, 19:31
DNTH Magenta Therapeutics, Inc. 28 Jun 2022 1 $0 4 Director 30 Jun 2022, 18:34
KYMR Kymera Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 16:05
BPMC Blueprint Medicines Corp 16 May 2022 7 -$949K 4 Director 18 May 2022, 16:05
BPMC Blueprint Medicines Corp 06 Apr 2022 3 -$276K 4 CEO AND PRESIDENT, Director 08 Apr 2022, 16:05
BPMC Blueprint Medicines Corp 03 Mar 2022 10 -$1.69M 4 CEO AND PRESIDENT, Director 08 Mar 2022, 15:06
BPMC Blueprint Medicines Corp 01 Mar 2022 2 $0 4 CEO AND PRESIDENT, Director 03 Mar 2022, 18:58
BPMC Blueprint Medicines Corp 15 Nov 2021 8 -$3.08M 4 CEO and President, Director 17 Nov 2021, 15:18
BPMC Blueprint Medicines Corp 01 Nov 2021 3 -$501K 4 CEO and President, Director 03 Nov 2021, 16:03
BPMC Blueprint Medicines Corp 26 Aug 2021 2 $29.9K 4 CEO and President, Director 30 Aug 2021, 16:04
BPMC Blueprint Medicines Corp 19 Aug 2021 6 -$2.04M 4 CEO and President, Director 23 Aug 2021, 16:24
KYMR Kymera Therapeutics, Inc. 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 16:44
DNTH Magenta Therapeutics, Inc. 01 Jun 2021 1 $0 4 Director 03 Jun 2021, 18:27
BPMC Blueprint Medicines Corp 12 May 2021 7 -$2.04M 4 CEO and President, Director 14 May 2021, 18:02